Purpose of the Procedure
- Monitoring the efficacy of chemotherapy, radiation, or immunotherapy.
- Early detection of molecular relapse before imaging appearance.
- Assessing minimal residual disease (MRD) after surgery.
Book Liquid Biopsy Treatment Monitoring | Lahalak Medical Platform
An advanced technology analyzing circulating tumor DNA (ctDNA) to monitor treatment efficacy in real-time. It empowers clinicians to make data-driven decisions and detect molecular relapse early for better patient outcomes.
Scientific name: Liquid Biopsy for Treatment Response Monitoring (ctDNA)
A sophisticated laboratory test measuring circulating tumor DNA (ctDNA) levels. It monitors cancer response to surgery or chemotherapy, enabling early detection of molecular relapse before it becomes visible on conventional imaging.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Venous blood sample collection
- Serial ctDNA analysis
- Detailed medical report
Medical Service Information
Target Groups
- Cancer patients undergoing active treatment regimens.
- Patients in the follow-up phase after tumor resection.
- Cases requiring close monitoring for treatment resistance.
Benefits of Liquid Biopsy
- Non-invasive procedure based on a simple blood draw.
- Ability to repeat the test periodically without pain.
- Providing a comprehensive real-time view of tumor genetic changes.
Conditions & Notices
- Previous treatment reports are preferred
- Testing intervals are determined by the treating physician
Medical services you might also like
